海思科

002653 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

57.1B ($8.3B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

3.7B

Net Income

466.0M

Gross Margin

N/A

Op. Margin

13.6%

Net Margin

12.5%

ROE

11.1%

ROA

6.9%

D/E

0.62

Dividend Yield

N/A

EPS

0.35

Current Ratio

1.74

Price History

Company Info

Industry	C27医药制造业
Market Segment	SME
Currency	CNY
Fiscal Year	2024

Business Overview

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmace...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 海思科

Ticker	002653
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业